LEO 29102 cream vehicle

LEO 29102 cream vehicle is the inactive topical formulation used as a placebo control in clinical trials for LEO 29102, an investigational phosphodiesterase-4 (PDE4) inhibitor developed by LEO Pharma. The vehicle is designed to be physically identical to the active LEO 29102 cream (2.5 mg/g) in terms of appearance, texture, and application, but it lacks the active PDE4 inhibitor compound. It was utilized in Phase 2 clinical trials for psoriasis vulgaris and atopic dermatitis to differentiate the therapeutic effects of the active drug from the effects of the cream base and the trial's placebo effect. Clinical development of the LEO 29102 program, including the vehicle-controlled studies, appears to have been discontinued.

Brand names

LEO 29102 cream vehicleLEO29102 cream vehicleLEO-29102 cream vehicle

Other names

LEO 29102 vehicleLEO29102 vehicleLEO-29102 vehicle